Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71,858,757
-
Total 13F shares
-
13,494,548
-
Share change
-
-163,813
-
Total reported value
-
$79,577,415
-
Price per share
-
$6.47
-
Number of holders
-
10
-
Value change
-
-$1,059,870
-
Number of buys
-
1
-
Number of sells
-
4
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q2 2024
As of 30 Jun 2024,
SINOVAC BIOTECH LTD. - Common Shares (SVA) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,494,548 shares.
The largest 10 holders included
Vivo Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, Neumann Advisory Hong Kong Ltd, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, WELLS FARGO & COMPANY/MN, MORGAN STANLEY, UBS Group AG, GROUP ONE TRADING, L.P., and Horizon Investments, LLC.
This page lists
10
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.